The use of prognostic and predictive factors for the treatment of breast cancer patients has both advantages and limitations when applied to the interpretation of microarray data in the clinical setting. This review focuses on the critical aspects of genomic parameters and how the information gleaned from microarray analysis can be used to enhance clinical therapy.
- Per Eystein Lønning
- Therese Sørlie
- Anne-Lise Børresen-Dale
